含三基序蛋白21加剧对乙酰氨基酚诱导的小鼠肝损伤OA
Tripartite motif containing protein 21 exacerbates acetaminophen-in-duced liver injury in mice
目的:明确含三基序蛋白21(TRIM21)在对乙酰氨基酚(APAP)诱导的小鼠药物性肝损伤(DILI)模型中的作用.方法:在小鼠正常肝细胞AML12(细胞模型)和C57BL/6小鼠(动物模型)上构建APAP诱导的小鼠DILI模型.细胞模型以0、2.5、5、7.5和12.5 mmol/L的APAP刺激AML12细胞24 h后取样,构建细胞DILI模型;此外,通过瞬时转染小鼠TRIM21基因过表达的质粒(OE-TRIM21)构建TRIM21过表达小鼠细胞模型并以7.5 mmol/L的APAP刺激24 h后取样.以APAP(400 mg/kg)诱导不同时间(0、6、24和48 h)构建DILI动物模型;此外,通过尾静脉注射小鼠TRIM21基因过表达的腺相关病毒8(AAV8)构建小鼠肝脏过表达TRIM21模型后,腹腔注射APAP(400 mg/kg),24 h后取样.采用HE染色观察动物模型各组中的肝损伤程度.通过血清生化、Western blot、RT-qPCR和免疫组化染色等技术检测细胞和动物模型各组中的TRIM21、抗氧化通路关键转录因子核因子E2相关因子2(NRF2)、醌氧化还原酶1(NQO1)、谷氨酸-半胱氨酸连接酶催化亚基(GCLC)、修饰亚基(GCLM)以及谷胱甘肽过氧化物酶3(GPX3)、细胞色素P450 2E1(CYP2E1)、高迁移率族蛋白B1(HMGB1)、细胞周期抑制蛋白p21和p16、增殖细胞核抗原(PCNA)与细胞周期蛋白(cyclin A、cyclin D和cyclin E)的mRNA和蛋白表达.结果:在APAP诱导的小鼠细胞及动物DILI模型中,TRIM21的mRNA和蛋白水平均显著上调(P<0.05),且功能研究显示,TRIM21过表达显著加剧了APAP引起的小鼠肝细胞损伤.具体主要表现为:下调NRF2及其下游靶分子NQO1、GCLC、GCLM和GPX3的表达(P<0.05),进而显著削弱抗氧化能力;显著上调CYP2E1(P<0.05),进一步增强APAP毒性代谢;促进HMGB1的释放;显著上调p21和p16,同时抑制PCNA、cyclin A、cyclin D和cyclin E(P<0.05),进而促进细胞周期阻滞.结论:在APAP诱导的小鼠DILI模型中,TRIM21呈高表达,且过表达TRIM21加剧APAP诱导的小鼠药物性肝损伤,显著减弱抗氧化能力,并增强毒性代谢,同时还促进细胞周期阻滞.
AIM:This study aimed to elucidate the role of tripartite motif containing protein 21(TRIM21)in drug-induced liver injury(DILI)mouse models induced by acetaminophen(APAP).METHODS:The APAP-induced DILI mouse models were established utilizing normal mouse hepatocytes(AML12)as the cellular model and C57BL/6 mice as the animal model.In the cellular model,AML12 cells were treated with APAP at concentrations of 0,2.5,5,7.5 and 12.5 mmol/L for 24 h.Additionally,a TRIM21-overexpressing(OE-TRIM2)mouse cell model was established by transient transfection with a plasmid encoding the mouse TRIM21 gene,and samples were collected 24 h after stimula-tion with 7.5 mmol/L APAP.In the animal model,APAP(400 mg/kg)was administered to induce DILI at various time points(0,6,24 and 48 h).Furthermore,following the establishment of a mouse model overexpressing TRIM21 in the liv-er via tail vein injection of an adeno-associated virus 8(AAV8)overexpressing the mouse TRIM21 gene,APAP(400 mg/kg)was administered intraperitoneally;sampling was conducted after 24 h.Liver injury was evaluated in each animal model group through HE staining.The expression levels of TRIM21,key antioxidant pathway transcription factors,includ-ing nuclear factor E2-related factor 2(Nrf2),quinone oxidoreductase 1(NQO1),glutamate-cysteine ligase catalytic sub-unit(GCLC),glutamate-cysteine ligase modifier subunit(GCLM),glutathione peroxidase 3(GPX3),cytochrome P450 2 E1(CYP2E1),high mobility group box 1(HMGB1),cell cycle suppressor proteins p21 and p16,proliferating cell nu-clear antigen(PCNA),and cyclins(cyclin A,cyclin D and cyclin E)were assessed at the mRNA and protein levels in both the cellular and animal model groups using serum biochemistry,Western blot,real-time quantitative PCR,and im-munohistochemical staining.RESULTS:In the APAP-induced DILI mouse model,TRIM21 expression was significantly upregulated at both the mRNA and protein levels(P<0.05).Functional studies demonstrated that TRIM21 overexpression markedly exacerbated APAP-induced hepatocyte damage in mice.This exacerbated damage was specifically characterized by down-regulation of NRF2 and its downstream target molecules,NQO1,GCLC,GCLM and GPX3,which significantly decreased the antioxidant capacity(P<0.05).Additionally,CYP2E1 was significantly upregulated,further enhancing the toxic metabolism of APAP(P<0.05).Furthermore,TRIM21 overexpression promoted the release of HMGB1 and markedly increased the expression of p21 and p16 but suppressed the expression of PCNA,cyclin A,cyclin D and cyclin E,thereby facilitating cell cycle arrest(P<0.05).CONCLUSION:In the APAP-induced DILI mouse model,TRIM21 expression is increased.This overexpression exacerbates hepatic cell injury,significantly reduces antioxidant capacity,in-tensifies toxic metabolism,and concurrently induces cell cycle arrest.
王蓉;周宇霞;刘露;袁菲;黎萍;黄亚莉;扈腊英;王青玉;刘艳;郭兵
贵州医科大学病理生理学教研室/贵州省常见慢性疾病发病机制及药物研究重点实验室,贵州 安顺 561113贵州医科大学病理生理学教研室/贵州省常见慢性疾病发病机制及药物研究重点实验室,贵州 安顺 561113贵州医科大学病理生理学教研室/贵州省常见慢性疾病发病机制及药物研究重点实验室,贵州 安顺 561113贵州医科大学病理生理学教研室/贵州省常见慢性疾病发病机制及药物研究重点实验室,贵州 安顺 561113贵州医科大学病理生理学教研室/贵州省常见慢性疾病发病机制及药物研究重点实验室,贵州 安顺 561113贵州医科大学病理生理学教研室/贵州省常见慢性疾病发病机制及药物研究重点实验室,贵州 安顺 561113贵州医科大学病理生理学教研室/贵州省常见慢性疾病发病机制及药物研究重点实验室,贵州 安顺 561113贵州医科大学病理生理学教研室/贵州省常见慢性疾病发病机制及药物研究重点实验室,贵州 安顺 561113贵州医科大学病理生理学教研室/贵州省常见慢性疾病发病机制及药物研究重点实验室,贵州 安顺 561113贵州医科大学病理生理学教研室/贵州省常见慢性疾病发病机制及药物研究重点实验室,贵州 安顺 561113
医药卫生
药物性肝损伤对乙酰氨基酚含三基序蛋白21氧化应激细胞周期阻滞
drug-induced liver injuryparacetamoltripartite motif containing protein 21oxidative stresscell cycle arrest
《中国病理生理杂志》 2026 (5)
895-905,11
国家自然科学基金资助项目(No.82460144)贵州省科技计划项目(黔科合支撑[2025]一般113号)贵州省教育厅(青年科技拔尖人才项目)(黔教技[2024]328号)贵州省卫生健康委科学技术基金项目(No.gzwkj2025-278)
评论